Abstract:Abstract Background In the biopharmaceutical industry, Escherichia coli ( E. coli ) strains are among the most frequently used bacterial hosts for producing recombinant proteins because they allow a simple process set-up and they are Food and Drug Administration (FDA)-approved for human applications. Widespread use of E. coli in biotechnology has led to the development of many different strains, and selecting an ideal host to produce a specific protein of interest is an important step in developing a production process. E. coli B and K–12 strains are frequently employed in large-scale production processes, and therefore are of particular interest. We previously evaluated the individual cultivation characteristics of E. coli BL21 and the K–12 hosts RV308 and HMS174. To our knowledge, there has not yet been a detailed comparison of the individual performances of these production strains in terms of recombinant protein production and system stability. The present study directly compared the T7-based expression hosts E. coli BL21(DE3), RV308(DE3), and HMS174(DE3), focusing on evaluating the specific attributes of these strains in relation to high-level protein production of the model protein recombinant human superoxide dismutase (SOD). The experimental setup was an exponential carbon-limited fed-batch cultivation with minimal media and single-pulse induction. Results The host strain BL21(DE3) produced the highest amounts of specific protein, followed by HMS174(DE3) and RV308(DE3). The expression system HMS174(DE3) exhibited system stability by retaining the expression vector over the entire process time; however, it entirely stopped growing shortly after induction. In contrast, BL21(DE3) and RV308(DE3) encountered plasmid loss but maintained growth. RV308(DE3) exhibited the lowest ppGpp concentration, which is correlated with the metabolic stress level and lowest degradation of soluble protein fraction compared to both other strains. Conclusions Overall, this study provides novel data regarding the individual strain properties and production capabilities, which will enable targeted strain selection for producing a specific protein of interest. This information can be used to accelerate future process design and implementation.

SuptoxD2.0: A second‐generation engineered Escherichia coli strain achieving further enhanced levels of recombinant membrane protein production

Functional Requirements for DjlA- and RraA-Mediated Enhancement of Recombinant Membrane Protein Production in the Engineered Escherichia coli Strains SuptoxD and SuptoxR

Heterologous erythromycin production across strain and plasmid construction

Enhanced Antioxidant Activity in Streptococcus thermophilus by High-Level Expression of Superoxide Dismutase

Improved, two-stage protein expression and purification via autoinduction of both autolysis and auto DNA/RNA hydrolysis conferred by phage lysozyme and DNA/RNA endonuclease

Enhanced CoQ10 Production by Genome Modification of Rhodobacter Sphaeroides Via Tn7 Transposition

Comparative Genomic and Transcriptomic Analysis Guides to Further Enhance the Biosynthesis of Erythromycin by an Overproducer

Enhanced expression of membrane proteins in E. coli with a PBAD promoter mutant: synergies with chaperone pathway engineering strategies

Optimizing heterologous protein production in the periplasm of E. coli by regulating gene expression levels

Translational regulation of periplasmic folding assistants and proteases as a valuable strategy to improve production of translocated recombinant proteins in Escherichia coli

Construction and Characterization of a Medium Copy Number Expression Vector Carrying Auto-Inducible dps Promoter to Overproduce a Bacterial Superoxide Dismutase in Escherichia coli

Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production

Development of a high yielding E. coli periplasmic expression system for the production of humanized Fab' fragments

In situ enhancement of surfactin biosynthesis in Bacillus subtilis using novel artificial inducible promoters.

Engineering Escherichia Coli for L‐homoserine Production

Development of a protein-solubilizing expression method based on the synergistic action of intein ΔI-CM and the solubility enhancer elastin-like polypeptide

Dissecting difference in heterologous protein secretion titer by Type III secretion system between strains of Salmonella enterica

Building a Highly Efficient Streptomyces Super-Chassis for Secondary Metabolite Production by Reprogramming Naturally-Evolved Multifaceted Shifts

Engineering an optimized expression operating unit for improved recombinant protein production in Escherichia coli

Improving heterologous polyketide production in Escherichia coli by transporter engineering

Chromosomal Engineering of Escherichia Coli for Efficient Production of Coenzyme Q10